She won it! The Max Foundation is thrilled to announce that Pat Garcia-Gonzalez has won the Union for International Cancer Control’s CEO Award for 2018!
The Union for International Cancer Control (UICC) is a membership organization that aims to reduce the global cancer burden and promote greater equity in cancer care. Each year the UICC grants awards that aim to identify and celebrate best practices and inspirational figures among their members.
Pat received the CEO Award at this year’s World Cancer Congress in Kuala Lumpur, for her tremendous contributions to equity in cancer care and her visionary leadership as Chief Executive Officer of The Max Foundation. She was cheered on by friends, colleagues, and Max team members from around the globe.
Said Pat: “It is such an honor to receive this award, but it is not only for me. It’s really for the entire Max team and for all our many partners. My thanks go out to them for their daily efforts in making The Max Foundation possible and working tirelessly to create a world where all people can face cancer with dignity and hope.”
Pat had been one of three finalists for the award, alongside Asem Mansour of King Hussein Cancer Center in Jordan, and Wondu Bekele Woldemariam of Mathiwos Wondu-YeEthiopia Cancer Society. Our thanks and congratulations go out to all three finalists.
The Max Foundation would like to thank all our partners – physicians, pharmaceutical manufacturers, distribution and diagnostics companies, donors and supporters, and of course, patient associations – we could not do what we do with you.
Most of all, we’d like to thank the 18 different patient associations from across Asia that sent letters in support of Pat’s nomination. You are the inspiration for all we do and we are so very grateful for your support.
Visit the UICC website to learn more about the awards, the finalists, and our collective work to reduce the global cancer burden.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Max Foundation Creates Subsidiary Organization, MaxAid, to Further Mission
Now in its 20th year, The Max Foundation is undergoing exciting strategic changes aimed at strengthening organizational efforts to improve global access to cancer treatment, care and support. To that end, we announce the launch of MaxAid, a subsidiary organization set up by The Max Foundation to further its mission. MaxAid is a Washington nonprofit corporation with its own IRS determination letter of 501(c)(3) public charity status.
The Max Foundation and International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Partner to Enhance the Care of CLL in Low- and Middle-Income Countries
iwCLL to provide training, medical, and programmatic guidance to support implementation of access program for innovative CLL therapy in 29 LMICs over the next three years SEATTLE, Washington – October 10, 2023 – The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients….
The Critical Role of Humanitarian Donations
In a recent commentary published in the Journal of Global Oncology, co-authors Pat Garcia-Gonzalez MA, Gilberto Lopes MD, Erin Schwartz and Lawrence Shulman MD, clearly outline the need and efficacy of humanitarian donation programs using lessons learned from the success of joint access initiatives between Novartis and The Max Foundation.
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.
